Purification and properties of a novel glycosaminoglycan depolymerase from Streptococcus intermedius strain UNS 35

Journal of Medical Microbiology

Volumn 44, Issue 5, 1996, Pages 381-389

  Shain, H ^a   Homer, K A ^a   Beighton, D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN DEPOLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME ANALYSIS; NONHUMAN; PEPTOSTREPTOCOCCUS INTERMEDIUS; PH; PRIORITY JOURNAL;

EID: 0029977788     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-44-5-381     Document Type: Article

References (39)

1. Parker MT, Ball LC. Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 1976; 9: 275-302.
2. Ball LC, Parker MT. The cultural and biochemical characters of Streptococcus milleri strains ioslated from human sources. J Hyg 1979; 82 63-78.
3. Poole PM, Wilson G. Occurrence and cultural features of Streptococcus milleri in various body sites. J. Clin Palhol 1979; 32: 764-768.
4. Shlaes DM, Lerner PI, Wolinsky E, Gopalakrishna KV. Infections due to Lancefield group F and related streptococci (S. milleri, S. anginosus). Medicine 1981; 60: 197-207.
5. Murray HW, Gross KC, Masur H, Roberts RB. Serious infections caused by Streptococcus milleri. Am J Med 1978; 64: 759-764.
6. Anonymous. Streptococcus milleri, pathogen in various guises. Lancet 1985; 2: 1403-1404.
7. Ruoff KL. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev 1988; 1: 102-108.
8. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH. Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 1992; 11: 491-498.
9. Whiley RA, Beighton D. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int J Syst Bacterial 1991; 41: 1-5.
10. Unsworth PF. Hyaluronidase production in Streptococcus milleri in relation to infection. J Clin Pathol 1989; 42 506-510.
11. Whiley RA, Fraser H, Hardie JM, Beighton D. Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group". J Clin Microbiol 1990; 28: 1497-1501.
12. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30: 243-244.
13. Beighton D, Hardie JM, Whiley RA. A scheme for the identification of viridans streptococci. J Med Microbiol 1991; 35 367-372.
14. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443-475.
15. Levvy GA, McAllan A. The N-acetylation and estimation of hexosamines. Biochem J 1959; 73: 127-132.
16. Homer KA, Patel R, Beighton D. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sobrinus SL-1. Infect Immun 1993; 61: 295-302.
17. Saito H, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem 1968; 243: 1536-1542.
18. Yamagata T, Saito H, Habuchi O, Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulphatases. J Biol Chem 1968; 243: 1523-1535.
19. Russell RRB. Comparison of oral Streptococcus mutans AHT with strains of serotypes a and g by biochemical and electrophoretic methods. Arch Oral Biol 1979; 24; 617-619.
20. Linn S, Chan T, Lipeski L, Salvers AA. Isolation and characterization of two chondroitin lyases from Bacteroides thetaiotaomicron. J Bacteriol 1983; 156: 859-866.
21. Slayne MA, Aldred MJ, Wade WG. A rapid, semi-automated SDS-PAGE identification system for oral anaerobic bacteria. J Appl Bacteriol 1990; 68: 391-395.
22. Linker A. Bacterial mucopolysaccharidases (mucopolysaccharide lyases). Methods Enzymol 1966: 8: 650-654.
23. Tipler LS, Embery G. Glycosaminoglycan-depolymerising enzymes produced by anaerobic bacteria isolated from the human mouth. Arch Oral Biol 1985; 30: 391-396.
24. Michelacci YM, Dietrich CP. Chondroitinase C from Flavobacterium heparinum. J Biol Chem 1976; 251: 1154-1158.
25. Michelacci YM, Dietrich CP. Isolation and partial characterization of an induced chondroitinase B from Flavobacterium heparinum. Biochem Biophys Res Commun 1974; 56: 973-980.
26. Hibi E, Osano E, Fujii Y, Moriyama T. Chondroitinase C activity of Streptococcus intermedius. FEMS Microbiol Lett 1989; 57: 121-124.
27. Gibian H. Enzymes degrading glycosaminoglycans. In: Balazs EA, Jeanloz R (eds) The amino sugars, vol 2B, Metabolism and interactions. New York, Academic Press. 1966: 181-200.
28. Hill J. Purification and properties of streptococcal hyaluronate lyase. Infect Immun 1976; 14: 726-735.
29. Hamai A, Morikawa K, Horie K, Tokuyasu K. Purification and characterization of hyaluronidase from Streptococcus dysgalactiae. Agric Biol Chem 1989; 53: 2163-2168.
30. Sting R, Schaufuss P, Blobel H. Isolation and characterization of hyaluronidases from Streptococcus dysgalactiae, S zooepidemicus and S. equi. Int J Med Microbiol 1990; 272: 276-282.
31. Linker A, Meyer K, Hoffman P. The production of unsaturated uronides by bacterial hyaluronidases. J Biol Chem 1956; 219: 13-25.
32. Abramson C. Staphylococcal hyaluronidase isoenzyme profiles related to Staphylococcal disease. Ann NY Acad Sci 1974; 236: 495-507.
33. Kennedy JF. Enzymic susceptibilities of glycosaminoglycans and proteoglycans. In: Proteoglycans - biological and chemical aspects in human life. (Studies in organic chemistry 2) Amsterdam, Elsevier Scientific Publishing Company. 1979: 195-223.
34. Brunish R, Mozersky SM. The characterization of hyaluronidase isolated from Escherichia freundii. J Biol Chem 1958; 231: 291-301.
35. Tam Y-C, Chan ECS. Purification and characterization of hyaluronidase from oral Peptostreptococcus species. Infect Immun 1985; 47: 508-513.
36. Homer KA, Denbow L, Whiley RA, Beighton D. Chondroitin sulfate depolymerase and hyaluronidase activities of viridans streptococci determined by a sensitive spectrophotometric assay. J Clin Microbiol 1993; 31: 1648-1651.
37. Homer KA, Grootveld MC, Hawkes J, Naughton DP, Beighton D. Degradation of hyaluronate by Streptococcus intermedius strain UNS 35. J Med Microbiol 1994; 41: 414-422.
38. Rodén L. Structure and metabolism of connective tissue proteoglycans. In: Lennarz WJ (ed) The biochemistry of glycoproteins and proteoglycans. New York, Plenum Press. 1980 267-371. Reference added in proof:
39. Shain H, Homer KA, Beighton D. Degradation and utilisation of chondroitin sulphate by Streptococcus intermedius. J Med Microbiol 1996; 44: 372-380.